Hargesheim, Germany

Kai Donsbach

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Kai Donsbach

Introduction

Kai Donsbach is an accomplished inventor based in Hargesheim, Germany. He has made significant contributions to the field of chemistry, particularly in the development of processes for removing transition metals and creating pharmaceutical compositions. With a total of 2 patents, Donsbach's work showcases his innovative approach to solving complex chemical challenges.

Latest Patents

Donsbach's latest patents include a process for removing transition metals. This process involves diminishing the concentration of a transition metal complex from a first solution by adding a solubility-enhancing compound. This compound enhances the solubility of the complex in a second solution, allowing for effective extraction. Another notable patent is related to the crystalline form of telmisartan sodium. This invention pertains to a crystalline sodium salt of a specific compound, along with processes for preparing it and its use in pharmaceutical compositions.

Career Highlights

Throughout his career, Donsbach has worked with prominent companies in the pharmaceutical industry. He has been associated with Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma KG. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in his field.

Collaborations

Donsbach has collaborated with notable colleagues, including Michael Brenner and Thomas Nicola. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kai Donsbach's contributions to the field of chemistry through his patents and collaborations highlight his role as a significant inventor. His innovative processes and dedication to advancing pharmaceutical science continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…